These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 3871381)
1. Comparative study of serum amyloid A protein and C-reactive protein in disease. Maury CP Clin Sci (Lond); 1985 Feb; 68(2):233-8. PubMed ID: 3871381 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection. Maury CP; Teppo AM Clin Nephrol; 1984 Dec; 22(6):284-92. PubMed ID: 6441659 [TBL] [Abstract][Full Text] [Related]
3. Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio. Kokubun M; Imafuku Y; Okada M; Ohguchi Y; Ashikawa T; Yamada T; Yoshida H Clin Chim Acta; 2005 Oct; 360(1-2):97-102. PubMed ID: 15932751 [TBL] [Abstract][Full Text] [Related]
4. Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. Raynes JG; Cooper EH J Clin Pathol; 1983 Jul; 36(7):798-803. PubMed ID: 6863571 [TBL] [Abstract][Full Text] [Related]
5. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Nakayama T; Sonoda S; Urano T; Yamada T; Okada M Clin Chem; 1993 Feb; 39(2):293-7. PubMed ID: 8381732 [TBL] [Abstract][Full Text] [Related]
6. Examination of serum amyloid A protein in kidney transplant patients--comparison of serum amyloid A and C-reactive protein for monitoring the occurrence of renal-allograft-related complications. Fukuda Y; Kanbe M; Sumimoto R; Yoneya T; Takeshita T; Hoshino S; Shintaku S; Dohi K Hiroshima J Med Sci; 1998 Jun; 47(2):63-7. PubMed ID: 9674342 [TBL] [Abstract][Full Text] [Related]
7. Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases. Saiki O; Uda H Scand J Immunol; 2022 Feb; 95(2):e13121. PubMed ID: 34796986 [TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A in the assessment of early inflammatory arthritis. Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018 [TBL] [Abstract][Full Text] [Related]
9. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study. Jylhävä J; Haarala A; Eklund C; Pertovaara M; Kähönen M; Hutri-Kähönen N; Levula M; Lehtimäki T; Huupponen R; Jula A; Juonala M; Viikari J; Raitakari O; Hurme M J Intern Med; 2009 Sep; 266(3):286-95. PubMed ID: 19702793 [TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia. Uguccioni M; Meliconi R; Lalli E; Nesci S; Delfini C; Lucarelli G; Gasbarrini G; Facchini A J Clin Pathol; 1992 Apr; 45(4):348-51. PubMed ID: 1577974 [TBL] [Abstract][Full Text] [Related]
11. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ledue TB; Weiner DL; Sipe JD; Poulin SE; Collins MF; Rifai N Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():745-53. PubMed ID: 9838988 [TBL] [Abstract][Full Text] [Related]
12. [Inflammatory reaction and laboratory tests: serum amyloid A (SAA) protein]. Yamada T Rinsho Byori; 1990 Mar; 38(3):249-54. PubMed ID: 2112209 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein. Shimetani N; Shimetani K; Mori M Scand J Clin Lab Invest; 2004; 64(5):469-74. PubMed ID: 15276911 [TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein. Kumon Y; Loose LD; Birbara CA; Sipe JD J Rheumatol; 1997 Jan; 24(1):14-9. PubMed ID: 9002005 [TBL] [Abstract][Full Text] [Related]
15. Serum amyloid protein A (SAA): an indicator of inflammation in AIDS and AIDS-related complex (ARC). Husebekk A; Permin H; Husby G Scand J Infect Dis; 1986; 18(5):389-94. PubMed ID: 3095915 [TBL] [Abstract][Full Text] [Related]
16. Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease. Yarur AJ; Quintero MA; Jain A; Czul F; Barkin JS; Abreu MT Inflamm Bowel Dis; 2017 Jan; 23(1):158-164. PubMed ID: 27930409 [TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. Kosuge M; Ebina T; Ishikawa T; Hibi K; Tsukahara K; Okuda J; Iwahashi N; Ozaki H; Yano H; Kusama I; Nakati T; Umemura S; Kimura K Circ J; 2007 Feb; 71(2):186-90. PubMed ID: 17251664 [TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A, phospholipase A₂-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases. Menschikowski M; Hagelgans A; Fuessel S; Mareninova OA; Asatryan L; Wirth MP; Siegert G Inflamm Res; 2013 Dec; 62(12):1063-72. PubMed ID: 24061501 [TBL] [Abstract][Full Text] [Related]
19. Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker. Hwang YG; Balasubramani GK; Metes ID; Levesque MC; Bridges SL; Moreland LW Arthritis Res Ther; 2016 May; 18(1):108. PubMed ID: 27188329 [TBL] [Abstract][Full Text] [Related]
20. [Clinical importance of determination of serum amyloid A]. Jovanović DB Srp Arh Celok Lek; 2004; 132(7-8):267-71. PubMed ID: 15615187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]